{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:59:26Z","timestamp":1792828766906,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T00:00:00Z","timestamp":1152144000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The primary aim of treatment of a patient who has developed metastatic disease is palliation. The objectives of the current study are to describe and quantify the clinical management of women with metastatic breast cancer from the diagnosis of metastatic disease until death and to analyze differences between age groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data were collected from the medical files of all patients (n = 116) who had died after December 31, 1999, after a diagnosis of metastatic breast cancer in two teaching hospitals in the south of the Netherlands.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 116 patients included in our study, 10 (9%) already had metastatic disease at diagnosis and 106 developed distant disease after the diagnosis of localized breast cancer. Before they died, 70% of the 116 patients developed metastases in one or more bones, 50% in the lung and\/or pleura, 50% in the abdominal viscera, 23% in the central nervous system, and 19% in the skin. Patients younger than 50 years were much more likely to develop metastases in the central nervous system than patients 50 years and older. Seventy-seven (66%) of the 116 patients with metastatic breast cancer received chemotherapy. This proportion decreased with age (p = 0.005), as did the number of schemes per patient. Together, they received 132 chemotherapy schemes, of which 35 (27%) resulted in partial remission or stabilization of the disease process. Ninety-eight patients (84%) received hormonal treatment. This proportion did not differ between the three age groups. Together, they received 216 hormonal treatments, 38 (16%) of which resulted in partial remission or stabilization of the disease process. Seventy-nine patients (68%) received palliative radiotherapy. This proportion decreased with age (p = 0.03). Together, they underwent 216 courses, 176 (77%) of which resulted in relief of the complaints.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Patients aged 70 years and older are less likely to receive chemotherapy or radiotherapy. Part of this difference could be explained by their shorter survival time after the diagnosis of metastatic disease and their lower risk of developing brain and bone metastases. However, more research is needed to understand the age-related differences in the treatment of metastatic breast cancer, and especially how comorbidity and frailty limit therapeutic choices.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-6-179","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T18:35:48Z","timestamp":1152210948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Clinical management of women with metastatic breast cancer: a descriptive study according to age group"],"prefix":"10.1186","volume":"6","author":[{"given":"Klaartje","family":"Manders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke V","family":"van de Poll-Franse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert-Jan","family":"Creemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Vreugdenhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice JC","family":"van der Sangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grard AP","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi MH","family":"Roumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri C","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,7,6]]},"reference":[{"key":"531_CR1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1200\/JCO.1998.16.3.1030","volume":"16","author":"MJ Edwards","year":"1998","unstructured":"Edwards MJ, Gamel JW, Feuer EJ: Improvement in the prognosis of breast cancer from 1965 to 1984. J Clin Oncol. 1998, 16: 1030-1035.","journal-title":"J Clin Oncol"},{"key":"531_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cncr.11083","volume":"97","author":"J Chang","year":"2003","unstructured":"Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM: Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. 2003, 97: 545-553. 10.1002\/cncr.11083.","journal-title":"Cancer"},{"key":"531_CR3","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1200\/JCO.2004.08.095","volume":"22","author":"F Andre","year":"2004","unstructured":"Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, Kabbaj O, Spano JP, Marsiglia H, Rouzier R, Delaloge S, Spielmann M: Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol. 2004, 22: 3302-3308. 10.1200\/JCO.2004.08.095.","journal-title":"J Clin Oncol"},{"key":"531_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1006285726561","volume":"56","author":"A Insa","year":"1999","unstructured":"Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J: Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat. 1999, 56: 67-78. 10.1023\/A:1006285726561.","journal-title":"Breast Cancer Res Treat"},{"key":"531_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1023\/A:1006308619659","volume":"59","author":"EF Solomayer","year":"2000","unstructured":"Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G: Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat. 2000, 59: 271-278. 10.1023\/A:1006308619659.","journal-title":"Breast Cancer Res Treat"},{"key":"531_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/bjc.1998.52","volume":"77","author":"RE Coleman","year":"1998","unstructured":"Coleman RE, Smith P, Rubens RD: Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer. 1998, 77: 336-340.","journal-title":"Br J Cancer"},{"key":"531_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1008384019411","volume":"12","author":"M Ryberg","year":"2001","unstructured":"Ryberg M, Nielsen D, Osterlind K, Skovsgaard T, Dombernowsky P: Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy. Ann Oncol. 2001, 12: 81-87. 10.1023\/A:1008384019411.","journal-title":"Ann Oncol"},{"key":"531_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/cncr.20418","volume":"101","author":"R Lai","year":"2004","unstructured":"Lai R, Dang CT, Malkin MG, Abrey LE: The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma. Cancer. 2004, 101: 810-816. 10.1002\/cncr.20418.","journal-title":"Cancer"},{"key":"531_CR9","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/cncr.10541","volume":"94","author":"LJ Schouten","year":"2002","unstructured":"Schouten LJ, Rutten J, Huveneers HA, Twijnstra A: Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002, 94: 2698-2705. 10.1002\/cncr.10541.","journal-title":"Cancer"},{"key":"531_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.clon.2004.03.012","volume":"16","author":"AJ Evans","year":"2004","unstructured":"Evans AJ, James JJ, Cornford EJ, Chan SY, Burrell HC, Pinder SE, Gutteridge E, Robertson JF, Hornbuckle J, Cheung KL: Brain metastases from breast cancer: identification of a high-risk group. Clin Oncol (R Coll Radiol). 2004, 16: 345-349.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1097-0142(19950715)76:2<232::AID-CNCR2820760212>3.0.CO;2-0","volume":"76","author":"RJ Freilich","year":"1995","unstructured":"Freilich RJ, Seidman AD, DeAngelis LM: Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer. 1995, 76: 232-236. 10.1002\/1097-0142(19950715)76:2<232::AID-CNCR2820760212>3.0.CO;2-0.","journal-title":"Cancer"},{"key":"531_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ctrv.2005.04.008","volume":"31","author":"R Duchnowska","year":"2005","unstructured":"Duchnowska R, Szczylik C: Central nervous system metastases in breast cancer patients administered trastuzumab. Cancer Treat Rev. 2005, 31: 312-318. 10.1016\/j.ctrv.2005.04.008.","journal-title":"Cancer Treat Rev"},{"key":"531_CR13","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0895-4356(99)00098-0","volume":"52","author":"JW Coebergh","year":"1999","unstructured":"Coebergh JW, Janssen-Heijnen ML, Post PN, Razenberg PP: Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996. J Clin Epidemiol. 1999, 52: 1131-1136. 10.1016\/S0895-4356(99)00098-0.","journal-title":"J Clin Epidemiol"},{"key":"531_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.seminoncol.2003.12.033","volume":"31","author":"G Kimmick","year":"2004","unstructured":"Kimmick G, Muss HB: Breast cancer in older patients. Semin Oncol. 2004, 31: 234-248. 10.1053\/j.seminoncol.2003.12.033.","journal-title":"Semin Oncol"},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.1992.03490010059030","volume":"268","author":"K Christman","year":"1992","unstructured":"Christman K, Muss HB, Case LD, Stanley V: Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment]. Jama. 1992, 268: 57-62. 10.1001\/jama.268.1.57.","journal-title":"Jama"},{"key":"531_CR16","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/jnci\/86.23.1766","volume":"86","author":"SB Yellen","year":"1994","unstructured":"Yellen SB, Cella DF, Leslie WT: Age and clinical decision making in oncology patients. J Natl Cancer Inst. 1994, 86: 1766-1770.","journal-title":"J Natl Cancer Inst"},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/S0959-8049(02)00090-4","volume":"38","author":"M Extermann","year":"2002","unstructured":"Extermann M, Chen H, Cantor AB, Corcoran MB, Meyer J, Grendys E, Cavanaugh D, Antonek S, Camarata A, Haley WE, Balducci L: Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer. 2002, 38: 1466-1473. 10.1016\/S0959-8049(02)00090-4.","journal-title":"Eur J Cancer"},{"key":"531_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/annonc\/mdh062","volume":"15","author":"L Biganzoli","year":"2004","unstructured":"Biganzoli L, Goldhirsch A, Straehle C, Castiglione-Gertsch M, Therasse P, Aapro M, Minisini A, Piccart MJ: Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG). Ann Oncol. 2004, 15: 207-210. 10.1093\/annonc\/mdh062.","journal-title":"Ann Oncol"},{"key":"531_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1023\/A:1010686118469","volume":"65","author":"ES Wai","year":"2001","unstructured":"Wai ES, Trevisan CH, Taylor SCM, Mates D, Jackson JS, Olivotto IA: Health system costs of metastatic breast cancer. Breast Cancer Res Treat. 2001, 65: 233-240. 10.1023\/A:1010686118469.","journal-title":"Breast Cancer Res Treat"},{"key":"531_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/bjc.1992.91","volume":"65","author":"SF Hurley","year":"1992","unstructured":"Hurley SF, Huggins RM, Snyder RD, Bishop JF: The cost of breast cancer recurrences. Br J Cancer. 1992, 65: 449-455.","journal-title":"Br J Cancer"},{"key":"531_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.298.6665.13","volume":"298","author":"K Holli","year":"1989","unstructured":"Holli K, Hakama M: Treatment of the terminal stages of breast cancer. Bmj. 1989, 298: 13-14.","journal-title":"Bmj"},{"key":"531_CR22","doi-asserted-by":"crossref","unstructured":"Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol. 1996, 14: 671-679.","DOI":"10.1200\/JCO.1996.14.2.671"},{"key":"531_CR23","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/S0959-8049(00)00325-7","volume":"36","author":"M Robain","year":"2000","unstructured":"Robain M, Pierga JY, Jouve M, Asselain B, Dieras V, Beuzeboc P, Palangie T, Dorval T, Extra JM, Scholl S, Pouillart P: Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer. Eur J Cancer. 2000, 36: 2301-2312. 10.1016\/S0959-8049(00)00325-7.","journal-title":"Eur J Cancer"},{"key":"531_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/annonc\/mdf101","volume":"13","author":"F Cardoso","year":"2002","unstructured":"Cardoso F, Di LA, Lohrisch C, Bernard C, Ferreira F, Piccart MJ: Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?. Ann Oncol. 2002, 13: 197-207. 10.1093\/annonc\/mdf101.","journal-title":"Ann Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-6-179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-6-179\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-6-179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-6-179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:42:51Z","timestamp":1630449771000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-6-179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-6-179","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,6]]},"assertion":[{"value":"3 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"179"}}